Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma.

Piras G, Monne M, Palmas AD, Calvisi A, Asproni R, Vacca F, Pilo L, Gabbas A, Latte G.

Clin Epigenetics. 2014 Aug 20;6(1):16. doi: 10.1186/1868-7083-6-16. eCollection 2014.

PMID:
25170349
[PubMed]
Free PMC Article
2.

The role of epigenetics in the biology of multiple myeloma.

Dimopoulos K, Gimsing P, Grønbæk K.

Blood Cancer J. 2014 May 2;4:e207. doi: 10.1038/bcj.2014.29.

PMID:
24786391
[PubMed - in process]
Free PMC Article
3.

Understanding the multiple biological aspects leading to myeloma.

Boyle EM, Davies FE, Leleu X, Morgan GJ.

Haematologica. 2014 Apr;99(4):605-12. doi: 10.3324/haematol.2013.097907. No abstract available.

PMID:
24688108
[PubMed - in process]
Free PMC Article
4.

Germinal center B-cells resist transformation by Kras independently of tumor suppressor Arf.

Mullins CD, Su MY, Hucthagowder V, Chu L, Lu L, Kulkarni S, Novack D, Vij R, Tomasson MH.

PLoS One. 2013 Jun 25;8(6):e67941. doi: 10.1371/journal.pone.0067941. Print 2013.

PMID:
23825691
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.

Kaiser MF, Johnson DC, Wu P, Walker BA, Brioli A, Mirabella F, Wardell CP, Melchor L, Davies FE, Morgan GJ.

Blood. 2013 Jul 11;122(2):219-26. doi: 10.1182/blood-2013-03-487884. Epub 2013 May 22.

PMID:
23699600
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prevalence of p16 methylation and prognostic factors in plasma cell myeloma at a single institution in Korea.

Kim H, Jekarl DW, Kim M, Kim Y, Lim J, Han K, Min CK.

Ann Lab Med. 2013 Jan;33(1):28-33. doi: 10.3343/alm.2013.33.1.28. Epub 2012 Dec 17.

PMID:
23301219
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

DNA methylation in multiple myeloma is weakly associated with gene transcription.

Jung S, Kim S, Gale M, Cherni I, Fonseca R, Carpten J, Salhia B.

PLoS One. 2012;7(12):e52626. doi: 10.1371/journal.pone.0052626. Epub 2012 Dec 20.

PMID:
23285118
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma.

Aoki Y, Nojima M, Suzuki H, Yasui H, Maruyama R, Yamamoto E, Ashida M, Itagaki M, Asaoku H, Ikeda H, Hayashi T, Imai K, Mori M, Tokino T, Ishida T, Toyota M, Shinomura Y.

Genome Med. 2012 Dec 22;4(12):101. doi: 10.1186/gm402. eCollection 2012.

PMID:
23259664
[PubMed]
Free PMC Article
9.

Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.

Zingone A, Kuehl WM.

Semin Hematol. 2011 Jan;48(1):4-12. doi: 10.1053/j.seminhematol.2010.11.003. Review.

PMID:
21232653
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BG, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H; International Myeloma Working Group.

Leukemia. 2009 Dec;23(12):2210-21. doi: 10.1038/leu.2009.174. Epub 2009 Oct 1. Review.

PMID:
19798094
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Centrosomes and myeloma; aneuploidy and proliferation.

Chng WJ, Fonseca R.

Environ Mol Mutagen. 2009 Oct;50(8):697-707. doi: 10.1002/em.20528. Review.

PMID:
19739237
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Genomic and proteomic biomarkers for cancer: a multitude of opportunities.

Tainsky MA.

Biochim Biophys Acta. 2009 Dec;1796(2):176-93. doi: 10.1016/j.bbcan.2009.04.004. Epub 2009 May 4. Review.

PMID:
19406210
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genetic events in the pathogenesis of multiple myeloma.

Chng WJ, Glebov O, Bergsagel PL, Kuehl WM.

Best Pract Res Clin Haematol. 2007 Dec;20(4):571-96. Review.

PMID:
18070707
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.

Dispenzieri A, Kyle RA, Katzmann JA, Therneau TM, Larson D, Benson J, Clark RJ, Melton LJ 3rd, Gertz MA, Kumar SK, Fonseca R, Jelinek DF, Rajkumar SV.

Blood. 2008 Jan 15;111(2):785-9. Epub 2007 Oct 17.

PMID:
17942755
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression.

Dib A, Peterson TR, Raducha-Grace L, Zingone A, Zhan F, Hanamura I, Barlogie B, Shaughnessy J Jr, Kuehl WM.

Cell Div. 2006 Oct 18;1:23.

PMID:
17049078
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk